Td Private Client Wealth LLC Collegium Pharmaceutical, Inc Transaction History
Td Private Client Wealth LLC
- $3.58 Trillion
- Q4 2024
A detailed history of Td Private Client Wealth LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Td Private Client Wealth LLC holds 2,007 shares of COLL stock, worth $60,129. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,007
Previous 1,707
17.57%
Holding current value
$60,129
Previous $66 Million
12.82%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding COLL
# of Institutions
246Shares Held
37.3MCall Options Held
59.3KPut Options Held
9.5K-
Black Rock Inc. New York, NY5.79MShares$174 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$79.1 Million1.45% of portfolio
-
Rubric Capital Management LP New York, NY2.35MShares$70.4 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$68.4 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$64.2 Million0.15% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.02B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...